Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

CDC-Authored Genomics and Precision Health Publications Database|Home|Public Health Genomics and Precision Health Knowledge Base (PHGKB)

CDC-Authored Genomics and Precision Health Publications Database


Last data update: Dec 09, 2024. (Total: 6442 publications)
   dataset
Filtered By:
Records 1-14 (of 14 Records)
Query Trace: Pilishvili T[original query]
Effectiveness of a messenger RNA vaccine booster dose against coronavirus disease 2019 among US healthcare personnel, October 2021-July 2022
Plumb ID , Mohr NM , Hagen M , Wiegand R , Dumyati G , Harland KK , Krishnadasan A , Gist JJ , Abedi G , Fleming-Dutra KE , Chea N , Lee J , Barter D , Brackney M , Fridkin SK , Wilson LE , Lovett SA , Ocampo V , Phipps EC , Marcus TM , Smithline HA , Hou PC , Lee LC , Moran GJ , Krebs E , Steele MT , Lim SC , Schrading WA , Chinnock B , Beiser DG , Faine B , Haran JP , Nandi U , Chipman AK , LoVecchio F , Talan DA , Pilishvili T .
Open Forum Infect Dis 2023 10 (10) ofad457 type
Application of a life table approach to assess duration of BNT162b2 vaccine-derived immunity by age using COVID-19 case surveillance data during the Omicron variant period
Sternberg MR , Johnson A , King J , Ali AR , Linde L , Awofeso AO , Baker JS , Bayoumi NS , Broadway S , Busen K , Chang C , Cheng I , Cima M , Collingwood A , Dorabawila V , Drenzek C , Fleischauer A , Gent A , Hartley A , Hicks L , Hoskins M , Jara A , Jones A , Khan SI , Kamal-Ahmed I , Kangas S , Kanishka F , Kleppinger A , Kocharian A , León TM , Link-Gelles R , Lyons BC , Masarik J , May A , McCormick D , Meyer S , Milroy L , Morris KJ , Nelson L , Omoike E , Patel K , Pietrowski M , Pike MA , Pilishvili T , Peterson Pompa X , Powell C , Praetorius K , Rosenberg E , Schiller A , Smith-Coronado ML , Stanislawski E , Strand K , Tilakaratne BP , Vest H , Wiedeman C , Zaldivar A , Silk B , Scobie HM .
PLoS One 2023 18 (9) e0291678
Effectiveness of booster doses of monovalent mRNA COVID-19 vaccine against symptomatic severe acute respiratory syndrome coronavirus 2 infection in children, adolescents, and adults during omicron subvariant BA.2/BA.2.12.1 and BA.4/BA.5 predominant periods
Ciesla AA , Wiegand RE , Smith ZR , Britton A , Fleming-Dutra KE , Miller J , Accorsi EK , Verani JR , Shang N , Derado G , Pilishvili T , Link-Gelles R .
Open Forum Infect Dis 2023 10 (5) ofad187
Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization.
Feikin DR , Higdon MM , Andrews N , Collie S , Deloria Knoll M , Kwong JC , Link-Gelles R , Pilishvili T , Patel MK .
Vaccine 2023 41 (14) 2329-2338
SARS-CoV-2 infection history and antibody response to three COVID-19 mRNA vaccine doses.
Herring MK , Romine JK , Wesley MG , Ellingson KD , Yoon SK , Caban-Martinez AJ , Meece J , Gaglani M , Grant L , Olsho LEW , Tyner HL , Naleway AL , Khan SM , Phillips AL , Schaefer Solle N , Rose S , Mak J , Fuller SB , Hunt A , Kuntz JL , Beitel S , Yoo YM , Zheng PQ , Arani G , Mayo Lamberte J , Edwards T , Thompson MG , Sprissler R , Thornburg NJ , Lowe AA , Pilishvili T , Uhrlaub JL , Lutrick K , Burgess JL , Fowlkes AL .
Clin Infect Dis 2022 76 (10) 1822-1831 type
Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents - 19 States, March 29-July 25, 2022.
McConeghy KW , White EM , Blackman C , Santostefano CM , Lee Y , Rudolph JL , Canaday D , Zullo AR , Jernigan JA , Pilishvili T , Mor V , Gravenstein S .
MMWR Morb Mortal Wkly Rep 2022 71 (39) 1235-1238
Effectiveness of COVID-19 vaccination against SARS-CoV-2 Infection among Residents of US Nursing Homes, Before and During the Delta variant Predominance, December 2020 - November 2021.
Hatfield KM , Baggs J , Wolford H , Fang M , Sattar AA , Montgomery KS , Jin S , Jernigan J , Pilishvili T .
Clin Infect Dis 2022 75 S147-S154
Cost-effectiveness of implementing 13-valent pneumococcal conjugate vaccine for U.S. adults aged 19 years and older with underlying conditions.
Kobayashi M , Stoecker C , Xing W , Cho BH , Pilishvili T .
Hum Vaccin Immunother 2021 17 (7) 1-9
Invasive pneumococcal strain distributions and isolate clusters associated with persons experiencing homelessness during 2018.
Metcalf BJ , Chochua S , Walker H , Tran T , Li Z , Varghese J , Snippes Vagnone PM , Lynfield R , McGee L , Li Y , Pilishvili T , Beall B .
Clin Infect Dis 2020 72 (12) e948-e956 type
Upsurge of conjugate vaccine serotype 4 invasive pneumococcal disease clusters among adults experiencing homelessness in California, Colorado, and New Mexico.
Beall B , Walker H , Tran T , Li Z , Varghese J , McGee L , Li Y , Metcalf BJ , Gierke R , Mosites E , Chochua S , Pilishvili T .
J Infect Dis 2020 223 (7) 1241-1249 type
Multistate population and whole genome sequence based strain surveillance of invasive pneumococci recovered in the United States during 2017.
Varghese J , Chochua S , Tran T , Walker H , Li Z , Snippes Vagnone PM , Lynfield R , McGee L , Li Y , Metcalf B , Pilishvili T , Beall B .
Clin Microbiol Infect 2019 26 (4) 512 e1-512 e10 type
Genome-wide association analyses of invasive pneumococcal isolates identify a missense bacterial mutation associated with meningitis.
Li Y , Metcalf BJ , Chochua S , Li Z , Walker H , Tran T , Hawkins PA , Gierke R , Pilishvili T , McGee L , Beall BW .
Nat Commun 2019 10 (1) 178 type
A Population-Based Descriptive Atlas of Invasive Pneumococcal Strains Recovered Within the U.S. During 2015-2016.
Beall B , Chochua S , Gertz RE Jr , Li Y , Li Z , McGee L , Metcalf BJ , Ricaldi J , Tran T , Walker H , Pilishvili T .
Front Microbiol 2018 9 2670
Post-licensure surveillance of 13-valent pneumococcal conjugate vaccine (PCV13) in adults aged ⩾19years old in the United States, Vaccine Adverse Event Reporting System (VAERS), June 1, 2012-December 31, 2015.
Haber P , Arana J , Pilishvili T , Lewis P , Moro PL , Cano M .
Vaccine 2016 34 (50) 6330-6334
TOP